Macrolide immunomodulation of chronic respiratory diseases
- 1 January 2007
- journal article
- research article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 9 (1) , 7-13
Abstract
Important immunomodulatory properties of 14-and 15-membered macrolides may benefit patients with respiratory diseases associated with chronic inflammation. These properties include decreased neutrophil chemotaxis and infiltration into the respiratory epithelium, inhibition of transcription factors leading to decreased proinflammatory cytokine production, down-regulation of adhesion molecule expression, inhibition of microbial virulence factors including biofilm formation, reduced generation of oxygen-free radicals, enhanced neutrophil apoptosis, and decreased mucus hypersecretion with improved mucociliary clearance. Chronic, low-dose macrolides have dramatically improved survival in patients with diffuse panbronchiolitis (DPB). Given the overlap in pathogenesis between DPB and other chronic respiratory diseases, macrolides are being investigated for cystic fibrosis, asthma, chronic bronchitis, chronic sinusitis, and chronic obstructive pulmonary disease. Preliminary data (largely from open-label trials) are promising, but conclusive results are needed.Keywords
This publication has 38 references indexed in Scilit:
- Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trialThorax, 2006
- Macrolides and airway inflammation in childrenPaediatric Respiratory Reviews, 2005
- Macrolides in the treatment of asthma and cystic fibrosisRespiratory Medicine, 2005
- Anti-inflammatory effects of macrolides—an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?Journal of Antimicrobial Chemotherapy, 2005
- Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosisJournal of Antimicrobial Chemotherapy, 2004
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Fourteen-Member Macrolides Promote the Phosphatidylserine Receptor-Dependent Phagocytosis of Apoptotic Neutrophils by Alveolar MacrophagesAntimicrobial Agents and Chemotherapy, 2003
- Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappaB transcription factorsJournal of Antimicrobial Chemotherapy, 2002
- Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trialThorax, 2002
- Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthmaAnnals of Allergy, Asthma & Immunology, 2000